Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
Items 401–500 of 1,000
Karakas, M., Akın, İ., Burdelski, C. M., Clemmensen, P. M., Grahn, H., Jarczak, D., Keßler, M., Kirchhof, P. F., Landmesser, U., Lezius, S., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00439-2 · Cited by 47
Early Diagnosis and Evidence-Based Care of Surgical Sepsis
Moore, L. J., & Moore, F. A. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611408690 · Cited by 46
“A recent multicenter, randomized controlled trial comparing norepinephrine to dopamine for the treatment of shock demonstrated no significant difference in mortality.(30) However, patients that received dopamine had more arrhythmic events than patients receiving norepinephrine.”
BackgroundEarly vasopressin reduces incidence of new onset arrhythmias
Reardon, D. P., DeGrado, J. R., Anger, K. E., & Szumita, P. M. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.03.005 · Cited by 46
Impact of a cardiac intensivist on mortality in patients with cardiogenic shock
Na, S. J., Park, T. K., Lee, G. Y., Cho, Y. H., Chung, C. R., Jeon, K., Suh, G. Y., Ahn, J., Carriere, K. C., Song, Y. B., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.082 · Cited by 46
Choque cardiogénico – fármacos inotrópicos e vasopressores
Amado, J., Gago, P., Santos, W., Mimoso, J., & de Jesus, I. (2016) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.08.004 · Cited by 46
Jozwiak, M., Géri, G., Laghlam, D., Boussion, K., Dolladille, C., & Nguyen, L. S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826446 · Cited by 45
“In particular; AMI was reported in <1% of patients (123).”
BackgroundResultPharmacologic therapies for acute cardiogenic shock
Nativi-Nicolau, J. N., Selzman, C. H., Fang, J. C., & Stehlik, J. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000057 · Cited by 45
Miles, L. F., Joshi, K., Ogilvie, E. H., Densem, C. G., Klein, A. A., Sullivan, M. J., Martinez, G. C., Sudarshan, C., Abu-Omar, Y., & Irons, J. F. (2016) · Anaesthesia · doi:10.1111/anae.13522 · Cited by 45
“Alternatively, the higher incidence of ventricular tachycardia and ventricular fibrillation seen in the GA group may be a reflection of the pro-arrhythmic effects of calcium chloride and dopamine infusion which were almost universally required if patients received GA [21].”
BackgroundJiang, L., Sheng, Y., Feng, X., & Wu, J. (2019) · Critical Care · doi:10.1186/s13054-019-2362-4 · Cited by 45
“Several clinical studies also reported early concomitant vasopressin, and norepinephrine therapy could reduce the dose of NE, shorten the time of achieving target mean arterial pressure, and reduce catecholamine-related complications [9, 10].”
BackgroundLauridsen, M. D., Rørth, R., Lindholm, M. G., Kjærgaard, J., Schmidt, M., Møller, J. E., Hassager, C., Torp-Pedersen, C. T., Gislason, G., Køber, L., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.08.012 · Cited by 45
Basic mechanisms in cardiogenic shock: part 1—definition and pathophysiology
Krychtiuk, K. A., Vrints, C. J., Wojta, J., Huber, K., & Speidl, W. S. (2022) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuac021 · Cited by 45
(2011) · Der Kardiologe · doi:10.1007/s12181-011-0349-8 · Cited by 45
Acute Kidney Injury in Cardiogenic Shock: An Updated Narrative Review
Singh, S., Kanwar, A., Sundaragiri, P. R., Cheungpasitporn, W., Truesdell, A. G., Rab, S. T., Singh, M., & Vallabhajosyula, S. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8080088 · Cited by 44
“The SOAP-II (Sepsis Occurrence in Acutely Ill Patient) trial that evaluated all comers with circulatory shock did not demonstrate any differences in RRT-free days (within 28-days) between norepinephrine and dopamine [85].”
Beurton, A., Ducrocq, N., Auchet, T., Groubatch, F., Falanga, A., Kimmoun, A., Girerd, N., Fay, R., Vanhuyse, F., Tran, N., et al. (2016) · Shock · doi:10.1097/shk.0000000000000579 · Cited by 44
“(3) clearly demonstrated that dopamine should not be used in patients with cardiogenic shock because it was found to increase arrhythmias and likely mortality.”
BackgroundFailure of Mean Arterial Pressure Goals to Improve Outcomes Following Penetrating Spinal Cord Injury
Readdy, W. J., Saigal, R., Whetstone, W. D., Mefford, A. N., Ferguson, A. R., Talbott, J. F., Inoue, T., Bresnahan, J. C., Beattie, M. S., Pan, J. Z., et al. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001249 · Cited by 44
“These results support the recent literature on SCI and traumatic injury as a whole.(20,24,25) In a randomized controlled trial, De Backer et al(24) showed that dopamine was linked to significantly more complications and adverse events compared with norepinephrine for vasopressor administration.”
ResultNorepinephrine improves cardiac function during septic shock, but why?
Backer, D. D., & Pinsky, M. R. (2017) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.11.069 · Cited by 44
Sepsis in children: federal clinical guideline (draft)
Lekmanov, A. U. (2021) · Russian Journal of Pediatric Surgery Anesthesia and Intensive Care · doi:10.17816/psaic969 · Cited by 44
Hawchar, F., Rao, C., Akil, A., Mehta, Y. B., Rugg, C., Scheier, J., Adamson, H., Deliargyris, E., & Molnár, Z. (2021) · Biomedicines · doi:10.3390/biomedicines9070768 · Cited by 44
“Septic shock is by far the most frequent type of shock (62%) and carries a very high mortality ranging from 40 to 80% [15].”
BackgroundGao, F., & Zhang, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.696138 · Cited by 44
“The Sepsis Occurrence in Acutely Ill Patients II Trial showed that dopamine is associated with a higher rate of arrhythmias in CS patients and the overall population, as well as a higher risk of mortality in the CS subgroup (5).”
BackgroundControversies regarding choice of vasopressor therapy for management of septic shock in animals
Silverstein, D. C., & Beer, K. S. (2015) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12282 · Cited by 44
Improving the Accuracy of Cardiovascular Component of the Sequential Organ Failure Assessment Score*
Yadav, H., Harrison, A. M., Hanson, A. C., Gajic, O., Kor, D. J., & Cartin‐Ceba, R. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000929 · Cited by 44
Fernando, S. M., Mathew, R., Sadeghirad, B., Brodie, D., Belley‐Côté, E. P., Thiele, H., van Diepen, S., Fan, E., Santo, P. D., Simard, T., et al. (2022) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-022-02337-7 · Cited by 43
“In a cardiogenic shock subgroup of the SOAP II trial, norepinephrine was associated with lower odds of mortality at 28 days compared with dopamine.(34) The OptimaCC trial compared norepinephrine to epinephrine in patients with cardiogenic shock.”
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock
Ferreira, J., & Bissell, B. D. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066616689548 · Cited by 43
Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence
Belletti, A., Landoni, G., Ломиворотов, В. В., Oriani, A., & Ajello, S. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.10.017 · Cited by 44
Udesen, N. L. J., Helgestad, O. K. L., Banke, A., Frederiksen, P. H., Josiassen, J., Jensen, L. O., Schmidt, H., Edelman, E. R., Chang, B. Y., Ravn, H. B., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2816-8 · Cited by 43
“Moreover, norepinephrine was associated with improved survival compared to dopamine in a subgroup analysis of 280 patients with CS [32].”
BackgroundShashikumara, J. K., & Swamy, B. E. K. (2020) · Sensors International · doi:10.1016/j.sintl.2020.100008 · Cited by 43
Uijl, E., Ye, D., Ren, L., Colafella, K. M. M., van Veghel, R., Garrelds, I. M., Lu, H. S., Daugherty, A., Hoorn, E. J., Nioi, P., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026426 · Cited by 43
Gurnani, P. K., Patel, G. P., Crank, C. W., Vais, D., Lateef, O., Akimov, S., BALK, R. A., & Simon, D. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.003 · Cited by 43
Vasoactive Agent Use in Septic Shock: Beyond First‐Line Recommendations
Sacha, G. L., Bauer, S. R., & Lat, I. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2220 · Cited by 43
Vasopressin in Sepsis and Other Shock States: State of the Art
García-Álvarez, R., & Arboleda-Salazar, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111548 · Cited by 42
Sundermeyer, J., Kellner, C., Beer, B. N., Besch, L., Dettling, A., Bertoldi, L. F., Blankenberg, S., Dauw, J., Dindane, Z., Eckner, D., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3082 · Cited by 42
Vallabhajosyula, S., Vallabhajosyula, S., Vaidya, V. R., Patlolla, S. H., Desai, V. K., Mulpuru, S. K., Noseworthy, P. A., Kapa, S., Egbe, A. C., Gersh, B. J., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001125 · Cited by 42
Mean arterial pressure maintenance following spinal cord injury: Does meeting the target matter?
Weinberg, J. A., Farber, S. H., Kalamchi, L. D., Brigeman, S. T., Bohl, M. A., Varda, B., Sioda, N. A., Radosevich, J. J., Chapple, K. M., & Snyder, L. A. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002953 · Cited by 42
Broilo, F. P., Meregalli, A., & Friedman, G. (2015) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20150042 · Cited by 42
“Volume expansion improves the prognosis,(1,2) whereas inappropriate use of vasoconstrictors leads to harmful tissue hypoperfusion.(3,4) However, volume expansion may prove ineffective or even deleterious, by worsening pre-existing heart failure or by degrading gas exchange in a mechanically ventilated patient.”
BackgroundInfluentialHuang, X., Lei, S., Zhu, M., Jiang, R., Huang, L.-Q., Xia, G.-L., & Zhi, Y. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1200290 · Cited by 42
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?
Lajoye, Q., Orieux, A., Boyer, A., Prével, R., & Jozwiak, M. (2025) · Critical Care · doi:10.1186/s13054-025-05540-2 · Cited by 41
“Norepinephrine is currently recommended as first-line vasopressor in patients with septic shock [5], since norepinephrine induces fewer cardiac arrhythmias than dopamine and epinephrine [19, 22] and lower myocardial oxygen consumption and less increase in heart rate than epinephrine [23].”
Pulmonary Hypertension in the Intensive Care Unit
Poor, H. D., & Ventetuolo, C. E. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.07.001 · Cited by 41
“Still, convincing evidence for the preferential use of norepinephrine in critically ill patients with PH comes from a large randomized trial of ICU patients with shock, in which norepinephrine use, as compared with dopamine use, was associated with decreased mortality at 28 days in the prespecified subgroup of patient…”
BackgroundYue, Y., Huo, F., & Yin, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04836 · Cited by 41
Vasopressor Use in Adult Patients
Ferguson-Myrthil, N. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31824e2294 · Cited by 41
“Both dopamine and norepinephrine raise cardiac index, which is a measure of cardiac output per body surface area, due to the beta-1 stimulation.(20) Dopamine raises stroke volume; however, it may interfere with the hypothalamic pituitary axis by decreasing concentrations of all anterior pituitary hormones except corti…”
BackgroundDelgado, T., Wolfe, B. M., Davis, G. E., & Ansari, S. A. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.04.004 · Cited by 41
Cooper, H. A., & Panza, J. A. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.07.009 · Cited by 41
Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy
Westaby, S., Kharbanda, R. K., & BANNING, A. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.194 · Cited by 40
“Data derived from pulmonary artery catheterization allows prediction of risk and is advisable for all patients with cardiogenic shock”
BackgroundVela, J. L. P., Benitez, J. C. M., González, M. C., López, M. Á. D. L. C., Pérez, R. H., Meneses, V. S., & Sáez, F. D. N. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2012.02.007 · Cited by 40
Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock
Rizk, M., Lapointe, A., Lefebvre, F., & Barrington, K. J. (2017) · Acta Paediatrica · doi:10.1111/apa.14112 · Cited by 40
CAR T-Cell-Associated Neurotoxicity: Current Management and Emerging Treatment Strategies
Rivera, A., May, S., Lei, M. M., Qualls, S., Bushey, K., Rubin, D. B., & Barra, M. E. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000302 · Cited by 40
Bloom, J. E., Andrew, E., Dawson, L. P., Nehme, Z., Stephenson, M., Anderson, D. J., Fernando, H., Noaman, S. Q., Cox, S., Milne, C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.45179 · Cited by 40
Towards a less invasive approach to the early goal-directed treatment of septic shock in the ED
Coen, D., Cortellaro, F., Pasini, S. M., Tombini, V., Vaccaro, A., Montalbetti, L., Cazzaniga, M., & Boghi, D. (2014) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2014.02.011 · Cited by 40
“This drug was still recommended by SSC at the time of the writing of our first protocol but has been discouraged in the next guidelines after new evidence emerged [47] and we amended the protocol accordingly.”
Döpp, D., & Groeneveld, A. B. J. (2013) · American Journal of Critical Care · doi:10.4037/ajcc2013748 · Cited by 40
Herz in der Sepsis: Molekulare Mechanismen, Diagnose und Therapie der septischen Kardiomyopathie
Märtin, L., Derwall, M., Thiemermann, C., & Schürholz, T. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0329-x · Cited by 40
Rivers, E. P., Jaehne, A. K., & Dagher, G. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511852091.010 · Cited by 40
Huang, H., Wu, C., Shen, Q., Xu, H., Fang, Y., & Mao, W. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.05.007 · Cited by 39
Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management
Sato, R., Hasegawa, D., Guo, S., Nuqali, A., & Moreno, J. E. P. (2025) · Journal of Intensive Care · doi:10.1186/s40560-024-00770-y · Cited by 39
“Furthermore, a previous clinical trial revealed that the use of dopamine, which is an inotropic agent, increased a risk of death compared to norepinephrine in cardiogenic shock [39].”
Chen, J., Kuo, G. C., Hung, C., Lin, Y., Chen, Y., Wu, M., Fang, J., Ku, S., Hwang, S., Huang, Y., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.02.013 · Cited by 39
Leisman, D. E., Handisides, D. R., Busse, L. W., Chappell, M. C., Chawla, L. S., Filbin, M. R., Goldberg, M. B., Ham, K. R., Khanna, A. K., Ostermann, M., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04910-6 · Cited by 39
“Vasodilatory shock, requiring vasopressor therapy, is common in ICU patients [1].”
BackgroundMechanical circulatory support in acute cardiogenic shock
Khan, M. H., Corbett, B., & Hollenberg, S. M. (2014) · F1000Prime Reports · doi:10.12703/p6-91 · Cited by 39
“In patients requiring vasopressors to support systemic blood pressure, norepinephrine is preferred to dopamine [8].”
BackgroundDeWitt, E. S., Black, K. J., Thiagarajan, R. R., DiNardo, J. A., Colan, S. D., McGowan, F. X. J., & Kheir, J. N. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00058.2016 · Cited by 40
“Further, no difference in cardiac index or survival was noted in a large clinical trial comparing dopamine and norepinephrine as primary therapies for septic shock (4).”
BackgroundApproach to Acute Heart Failure in the Emergency Department
Hunter, B. R., Martindale, J., Abdel-Hafez, O., & Pang, P. S. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.08.008 · Cited by 40
ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy
Chaudhry, D., Chacko, J., Govil, D., Samavedam, S., Javeri, Y., Kar, A., Arora, N., Gopal, P. B. N., Tyagi, N., Sodhi, K., et al. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24109 · Cited by 38
Jia, L., Wang, P., Li, C., & Xie, J. (2023) · Shock · doi:10.1097/shk.0000000000002193 · Cited by 38
Taton, O., Fagnoul, D., Backer, D. D., & Vincent, J. (2013) · Anaesthesia · doi:10.1111/anae.12341 · Cited by 38
“After oxygen administration, optimisation of cardiac output (CO) is the next step in early resuscitation, and fluid administration is often the first method used to increase CO [2, 3].”
MethodSelf-citationYataco, A. C., Aguinaga-Meza, M., Buch, K. P., & Disselkamp, M. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9514-7 · Cited by 38
“Nonetheless, dopamine has been associated with tachycardia in patients with PH, increased risk of arrhythmias in patients with septic shock, and increased mortality in patients with cardiogenic shock [113, 114] .”
BackgroundGuinot, P., Martin, A., Berthoud, V., Voizeux, P., Bartamian, L., Santangelo, E., Bouhemad, B., & Nguyen, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143164 · Cited by 38
“Dopamine [3] Dose and duration Negative No”
Clinical Update in Pediatric Sepsis: Focus on Children With Pre-Existing Heart Disease
Weiss, S. L., Nicolson, S. C., & Naim, M. Y. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.10.029 · Cited by 37
Hemodynamic management of cardiogenic shock in the intensive care unit
Lim, H. S., González‐Costello, J., Bělohlávek, J., Zweck, E., Blumer, V. L., Schrage, B., & Hanff, T. C. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.03.009 · Cited by 37
“…have comparable effects on short-term survival, 46 • Dopamine as vasopressor (> 10 mcg/kg/min) compared with norepinephrine was associated with increased mortality, 47 • Epinephrine compared with norepinephrine was associated with a higher incidence of refractory CS and mortality in AMI-CS.”
Nguyen, H. M., Schiavoni, A., Scott, K., & Tanios, M. A. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02939.x · Cited by 37
Daley, M. J., Lat, I., Mieure, K. D., Jennings, H. R., Hall, J. B., & Kress, J. P. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r442 · Cited by 37
“ICU length of stay (days), median (IQR) 7 (3-15) 7 (4-24) 0.”
BackgroundNedel, W. L., Rech, T. H., Ribeiro, R. A., Pellegrini, J. A. S., & Moraes, R. B. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003471 · Cited by 37
Management of Right Ventricular Failure in Pulmonary Embolism
Zhao, S., & Friedman, O. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2020.02.006 · Cited by 37
How, O.-J., Rösner, A., Kildal, A. B., Stenberg, T. A., Gjessing, P. F., Hermansen, S. E., & Myrmel, T. (2010) · Translational research · doi:10.1016/j.trsl.2010.07.011 · Cited by 37
Long, B., Koyfman, A., & Gottlieb, M. A. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.08.002 · Cited by 37
The surviving sepsis campaign: 2013 and beyond
Dellinger, P. R. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130920 · Cited by 37
“A 2010 study, although not achieving statistical significance, showed better outcome with norepinephrine as opposed to dopamine in all forms of shock, with a concerning occurrence of lifethreatening arrhythmias with dopamine.(10) A 2012 metaanalysis also supports norepinephrine as a preferred agent when compared to do…”
Manejo del paciente en shock séptico
Bruhn, A. R., Pairumani, R., & Glenn Hernández, P. (2011) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(11)70429-1 · Cited by 36
Schenk, J., van der Ven, W. H., Schuurmans, J., Roerhorst, S., Cherpanath, T. G. V., Lagrand, W. K., Thoral, P., Elbers, P., Tuinman, P. R., Scheeren, T., et al. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.05.023 · Cited by 36
Gender Disparities in Cardiogenic Shock Treatment and Outcomes
Bloom, J. E., Andrew, E., Nehme, Z., Beale, A. L., Dawson, L. P., Shi, W. Y., Vriesendorp, P. A., Fernando, H., Noaman, S. Q., Cox, S., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.04.047 · Cited by 36
Rosland, R. G., Hagen, M. U., Haase, N., Holst, L. B., Plambech, M. Z., Madsen, K. R., Søe‐Jensen, P., Poulsen, L. M., Bestle, M. H., & Perner, A. (2014) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/1757-7241-22-14 · Cited by 36
“The mortality rate was high as observed in recent pragmatic trials including patients with septic shock [20,21].”
BackgroundIs There a Good MAP for Septic Shock?
Russell, J. A. (2014) · New England Journal of Medicine · doi:10.1056/nejme1402066 · Cited by 36
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Silvestri, L., & van Saene, H. K. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1006641 · Cited by 36
High versus low blood-pressure target in septic shock.
Asfar, P., Teboul, J., & Radermacher, P. (2014) · PubMed · doi:10.1056/nejmc1406276 · Cited by 35
Acute Heart Failure Management
Čerlinskaitė‐Bajorė, K., Javanainen, T., Cinotti, R., & Mebazaa, A. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0125 · Cited by 35
Stolz, A., Efendy, R., Apte, Y., Craswell, A., Lin, F. F., & Ramanan, M. (2021) · Australian Critical Care · doi:10.1016/j.aucc.2021.08.005 · Cited by 35
Motiejūnaitė, J., Deniau, B., Blet, A., Gayat, É., & Mebazaa, A. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.101012 · Cited by 35
Alternatives to norepinephrine in septic shock: Which agents and when?
Jozwiak, M. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.05.001 · Cited by 35
“[26] De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al.”
BackgroundZhang, Y., Zou, J., Wan, F., Peng, F., & Peng, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114522 · Cited by 35
Allen, L. A., Fonarow, G. C., Grau‐Sepulveda, M. V., Hernandez, A. F., Peterson, P. N., Partovian, C., Li, S., Heidenreich, P. A., Bhatt, D. L., Peterson, E. D., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000761 · Cited by 35
Validation of a care protocol for the septic patient in the Intensive Care Unit
Pedrosa, K. K. D. A., de Oliveira, S. A., & Machado, R. C. (2018) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2017-0312 · Cited by 35
Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy?
Levy, J. H., Ghadimi, K., Faraoni, D., van Diepen, S., Lévy, B., Hotchkiss, R. S., Connors, J. M., Iba, T., & Warkentin, T. E. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14566 · Cited by 35
O’Brien, C., Beaubien‐Souligny, W., Amsallem, M., Denault, A. Y., & Haddad, F. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.020 · Cited by 35
Post Myocardial Infarction Cardiogenic Shock: A Review of Current Therapies
Ng, R., & Yeghiazarians, Y. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611411407 · Cited by 35
“A recently published study comparing the use of norepinephrine and dopamine in patients with shock challenges the preferential use of dopamine over norepinephrine.(21) De Backer et al examined the randomized blinded first-line use of dopamine or norepinephrine in 1679 patients presenting with various types of shocks.”
BackgroundHemodynamic Support for Ventricular Tachycardia Ablation
Palaniswamy, C., Miller, M. A., Reddy, V. Y., & Dukkipati, S. R. (2016) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2016.10.011 · Cited by 34
Predictors of dysrhythmias with norepinephrine use in septic shock
Wieruszewski, E. D., Jones, G. M., Samarin, M. J., & Kimmons, L. A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.10.023 · Cited by 34
Heart Transplantation for Advanced Heart Failure
Westerdahl, D. E., & KOBASHIGAWA, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00048-5 · Cited by 34
Time-Sensitive Approach in the Management of Acute Heart Failure
Shiraishi, Y., Kawana, M., Nakata, J., Sato, N., Fukuda, K., & Kohsaka, S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13139 · Cited by 34
“The aforementioned mechanism that leads to systemic congestion through renal and dietary factors possibly contributes to the development of AHF.”
BackgroundInfluentialBignami, E. G., Belletti, A., Moliterni, P., Frati, E., Guarnieri, M., & Tritapepe, L. (2015) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-015-9725-4 · Cited by 34
Angiotensin II: a new therapeutic option for vasodilatory shock
Bussard, R. L., & Busse, L. W. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s150434 · Cited by 34
Mitric, G., Udy, A. A., Bandeshe, H., Clément, P., & Boots, R. J. (2016) · Critical Care · doi:10.1186/s13054-016-1252-2 · Cited by 33
“Defined risks include: use of catecholamines and positive inotropic drugs [8, 11, 12], high severity of disease index scores [1, 5, 9, 13], sepsis [1, 5], cardiovascular disease [4, 9, 12, 13], electrolyte disturbances [4], advanced age [9, 12, 13], elevated markers of inflammation [5, 6], hypoxia [5], and high centra…”
BackgroundVasopressor use in cardiogenic shock
Lévy, B., Klein, T., & Kimmoun, A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000743 · Cited by 33
“Norepinephrine has numerous advantages when compared with other vasopressors, including: a very potent vasopressor effect equivalent to epinephrine and phenylephrine and greater than dopamine [20]; contrary to epinephrine, norepinephrine does not act on b2 adrenergic receptors, hence lactate levels do not increase and…”
BackgroundResultChen, Y., Chang, S.-C., Pu, C., & Tang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077414 · Cited by 33
“In addition, it has been found that dopamine increases the risk of arrhythmia when compared with norepinephrine [25-27].”
BackgroundOrbegozo, D., Mongkolpun, W., Stringari, G., Μάρκου, Ν., Créteur, J., Vincent, J., & Backer, D. D. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0393-7 · Cited by 33
“Times from ICU admission until the first measurement were similar in survivors and non-survivors: 6 (4–17) versus 7 (5–14) h (p = 0.59).”
BackgroundInfluentialSelf-citationBurban, M., Hamel, J., Tabka, M., Bourdonnaye, M. R. D. L., Duveau, A., Mercat, A., Calès, P., Asfar, P., & Lerolle, N. (2013) · Critical Care · doi:10.1186/cc12818 · Cited by 33
“Moreover, septic shock patients require vasoconstrictor infusion, mostly norepinephrine (NE), in addition to fluid loading, to maintain blood pressure which may add another level of complexity to the vascular abnormalities observed in sepsis [11].”
BackgroundKhoury, N., & McGill, J. B. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1212 · Cited by 34
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.